Conley Chee

Conley Chee is a seasoned executive in the pharmaceutical industry, currently serving as the Global Head of Portfolio Management, Early Commercial Strategy, and Diagnostics at Novartis Oncology since October 2018. In this role, he is responsible for shaping the company's oncology pipeline and driving commercial planning for early-stage products and diagnostics.12

Professional Background

• Novartis Oncology (2018 - Present): Chee has held several leadership roles at Novartis, including Vice President and Global Head of the Lung Franchise. His experience encompasses various aspects of sales and marketing within oncology, contributing to the launch and management of targeted therapies.12
• Syros Pharmaceuticals (2021 - Present): Recently appointed as the Chief Commercial Officer at Syros Pharmaceuticals, Chee leads efforts to build a commercial organization focused on advancing cancer treatments. His expertise in oncology commercial leadership is pivotal for Syros as it develops its portfolio of investigational medicines.13
• Pfizer Pharmaceuticals (2001 - 2006): Before joining Novartis, he worked at Pfizer in international business development, enhancing his strategic acumen in the pharmaceutical sector.2

Education

Chee holds an MBA from the Richard Ivey School of Business at the University of Western Ontario and a B.Sc. in Pharmacy from the University of Alberta. He also completed his residency in Clinical Pharmacy at the University of British Columbia.12

Skills and Expertise

With over 20 years of experience in pharmaceutical sales, marketing, and strategy, Chee has a proven track record in:

• Developing and executing commercial strategies for novel cancer therapies.
• Building effective commercial organizations.
• Leading cross-functional teams to achieve strategic objectives in oncology.12

Chee's extensive background makes him a key player in advancing oncology treatments and shaping commercial strategies within leading pharmaceutical companies.